Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) and antiphospholipid syndrome have an increased risk to develop cognitive impairment. A possible role for antiphospholipid antibodies (aPL) and antiglutamate receptor (anti-NMDA) antibodies in the pathogenesis of neurological manifestations of these two conditions,...

Full description

Bibliographic Details
Main Authors: Gerosa, Maria, Poletti, Barbara, Pregnolato, Francesca, Castellino, Gabriella, Lafronza, Annalisa, Silani, Vincenzo, Riboldi, Piersandro, Meroni, Pier Luigi, Merrill, Joan T.
Format: Online
Language:English
Published: Frontiers Media S.A. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740786/